baber/WOPTO huggingface dataset:
Patent AU-6479200-A (AU)
Title: Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
Inventor: SEO MIN-HYO
IPC: A61K33/24
Filed: 2000-08-10
Abstract: A composition capable of forming a micelle in body fluids or in an aqueous medium and that can be injected into the body undiluted or as a diluted solution in an aqueous medium and method of preparation are disclosed. The composition comprises an amphiphilic block copolymer having a hydrophilic poly(alkyleneglycol) component and hydrophobic biodegradable polymer component, suspended in a poly (alkyleneglycol) medium. Such composition is used in the solubilization and administration of a poorly water-soluble drug.
Patent AU-6574794-A (AU)
Title: Apparatus for collecting data
Inventor: PAPAKOSTOPOULOS DEMETRIUS
IPC: A61B3/06
Filed: 1994-04-26
Abstract: PCT No. PCT/GB94/00883 Sec. 371 Date Apr. 4, 1996 Sec. 102(e) Date Apr. 4, 1996 PCT Filed Apr. 26, 1994 PCT Pub. No. WO94/24926 PCT Pub. Date Nov. 10, 1994An apparatus is provided for collecting data. The apparatus is particularly, but not exclusively, applicable for the diagnosing of eye disorders. The apparatus contains a rack (1) having a plurality of engagement positions and a plurality of counters (5) for the rack (1), each counter (5) being engageable in any one of the engagement positions. Each counter (5) contains a specific, unique, electrical attribute which enables a detector included within the apparatus to detect and therefore process the data relating to the value of the electrical attribute of each counter (5).
Patent AU-6653800-A (AU)
Title: DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof
Inventor: BIERING EIRIK
IPC: A61K38/00
Filed: 2000-10-16
Abstract: The present invention concerns a nucleic acid sequence encoding a structural protein of Infectious Salmon Anaemia Virus (ISAV) designated as Structural Protein-1 (SP-1), the isolated SP-1 protein, and use of said nucleic acid and/or protein for diagnostic or vaccine purposes. The invention furthermore pertains to antibodies that are reactive with said SP-1 and their use in diagnostics. <IMAGE>
Patent AU-6725594-A (AU)
Title: Gps explorer
Inventor: TAYLOR WILLIAM MICHAEL FREDERI
IPC: H04W4/06
Filed: 1994-05-18
Abstract: This is a portable information system which uses Global Positioning System (GPS) data as a key to automatically retrieve audiovisual data from a database. On a journey the system can automatically identify and describe places of specific interest to the user, landmarks and the history of nearby buildings, or locate hotels, hospitals, shops and products within a radius of the present position. Audible menus and voice command give hands-free and eyes-free control while driving, flying, sailing or walking.
Patent AU-6725900-A (AU)
Title: Fat or oil composition
Inventor: MASUI KENJI
IPC: A23L1/30
Filed: 2000-08-23
Abstract: Described is a fat or oil composition which comprises at least 35 wt.% of a diacylglycerol, the constituent fatty acids of said diacylglycerol satisfying the following equation: (an amount of a cis-form unsaturated fatty acid) / (an amount of a saturated fatty acid + an amount of a trans-form unsaturated fatty acid) ¥ 6. Usual intake of the fat or oil composition of the present invention as an edible oil makes it possible to reduce arteriosclerotic factors in blood, leading to the prevention of arteriosclerosis, furthermore, various degenerative diseases.
Patent AU-6747401-A (AU)
Title: Hypotensive and hypertensive properties of renomedullar extracts
Inventor: GLODNY BERNHARD
IPC: A61K35/22
Filed: 2001-05-22
Abstract: Isolation of hypotensive active agent (A) from mammalian renal medulla involves: (i) extracting dried renal medulla with organic solvent (I) of dielectric constant 2-45; (ii) chromatographing the extract on hydrophilic sorbent using an eluant gradient from non-polar to polar; and (iii) recovering (A) as extract after removal of eluant. Independent claims are included for: (a) the isolation of a hypertensive active agent (B) from mammalian renal medulla, by steps (i) and (ii) as above, followed by recovering a residue after removal of the eluant and recovering (B) by gel chromatography of the residue using an organic solvent (II) of dielectric constant 2-45; and (b) the agents (A) and (B) obtained by the above processes.
Patent AU-6766790-A (AU)
Title: A method for increasing the durability of refractory vessel linings
IPC: F27D1/04
Filed: 1990-11-30
Abstract: The process, by means of which the durability of refractory linings in vessels, which contain inclined regions or conical parts in the inner contour, is controlled, comprises oblique laying of the refractory bricks, following the inner contour of the vessel. The inclined position of the bricks is accomplished stepwise by means of a plurality of layers of deflection bricks suitable for machine pressing and having a known, uniform density. By means of this process, softer transitions from horizontal to oblique brick laying can be achieved. <IMAGE>
Patent AU-6872694-A (AU)
Title: Vector for integration site independent gene expression in mammalian host cells
Inventor: ECCLES SARAH JANE
IPC: A61K48/00
Filed: 1994-07-26
Abstract: A vector for the integration of a gene into the genetic material of a mammalian host cell such that the gene may be expressed by the host cell. The vector comprises a promoter and the gene and an immunoglobulin dominant control region derived from the mouse  lambda immunoglobulin gene locus capable of eliciting host cell-type restricted, integration site independent, copy number dependent expression of the said gene. The DNaseI super hypersensitive site exemplified are i) about 2.35kb upstream of the CAP site of the rearranged  lambda 1 gene ii) about 2.5kb upstream of the genomic V lambda 2 segment or iii) about 30kb downstream of the rearranged lambda 1 gene. Mammalian host cells transformed with the vector are disclosed as are transgenic mammals transformed with the vector and a method of producing a polypeptide comprising culturing a transformed mammalian cell. A method of gene therapy comprising the steps of i) removing stem cells from the body of a mammal, ii) optionally killing stem cells remaining in the body, iii) transforming the removed stem cells with the vector containing a gene deficient or absent in the body, and iv) replacing the transformed stem cells in the body is also disclosed. Also disclosed is functional mouse immunoglobulin  lambda 1 enhancer consisting of a DNA sequence comprising all or a functional part of the DNA sequence between the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene and the SnaBI site 10 kb downstream of this Xho I site. The functional mouse immunoglobulin lambda 1 enhancer may comprise all or a functional part of i) the 1.3 kb first HindIII to HindIII DNA fragment downstream of the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene, ii) the 3.3 kb HindIII to HindIII DNA fragment downstream of the EcoRI site 3.8 kb downstream of the Xho I site in the rearranged mouse  lambda 1 gene and spanning the SnaBI site 10 kb downstream of this Xho I site.
Patent AU-6948391-A (AU)
Title: Blood testing and fingerprint identification method and device
Inventor: GUIRGUIS RAUOF
IPC: G01N1/28
Filed: 1991-01-18
Abstract: A method and device for testing for the presence of substances such as drugs in the blood while simultaneously positively identifying the test subject. The device comprises an absorbent pad (22) and a membrane (24) (preferably a nitro cellulose membrane) mounted to the absorbent pad (22). The absorbent pad (22) preferably contains a plurality of separated areas provided with different absorbed antibody having a specific receptor site for specific antigens produced by different predetermined drugs and a base area without antibodies. The method of testing comprises the steps of: (a) puncturing the finger of a test subject to obtain a quantity of blood on the finger, (b) covering the finger with a thin film of blood (11), (c) placing the finger on a membrane (24) containing antibodies specifically selected to bind antigens produced by the substances being tested for in the blood so that blood is deposited from the finger on the membrane; and (d) adding colour development solution to the membrane (22) to bring out a colour indicating presence or absence of a substance. <IMAGE>
Patent AU-7044594-A (AU)
Title: Surrogate tolerogenesis for the development of tolerance to xenografts
Inventor: BESCHORNER WILLIAM E
IPC: A61K35/26
Filed: 1994-05-24
Abstract: PCT No. PCT/US94/05844 Sec. 371 Date Jun. 6, 1995 Sec. 102(e) Date Jun. 6, 1995 PCT Filed May 24, 1994 PCT Pub. No. WO94/27622 PCT Pub. Date Dec. 8, 1993This invention provides a method for developing immune tolerance in xenogeneic organ graft recipients, in which lympho-hematopoietic cells from an intended organ graft recipient are differentiated within a xenogeneic surrogate, such as a fetal animal. After birth of the surrogate, the matured lympho-hematopoietic cells containing antigen specific regulatory cells, including suppressor cells, veto cells, select B cells, anti-idiotype antibodies, and other related factors responsible for antigen specific tolerance in a surrogate animal are reintroduced into the intended organ graft recipient, in conjunction with an organ transplant or a tissue transplant from the xenograft surrogate. The invention also provides an organ graft repopulated with cells from the intended organ graft recipient produced in a surrogate animal.
Patent AU-7086098-A (AU)
Title: Monitoring dust deposition
Inventor: LEIRFALL LASSE
IPC: G08B21/00
Filed: 1998-04-17
Abstract: A method for monitoring a contaminated, dirty or inflammable condition within an electrical consumer appliance, comprises using a measurement device to measure a parameter that indicates an amount of dust on a surface located within the electrical consumer appliance, and using an indicator to indicate when the amount of dust on the surface exceeds an acceptable limit.
Patent AU-7106794-A (AU)
Title: Magnetic cycle reaction
Inventor: MIAN ALEC
IPC: C12Q1/6844
Filed: 1994-06-08
Abstract: The invention provides a process for amplification of specific nucleic acid sequences based upon the separation of nucleic acid strands by an electromagnetic field. This means of separation allows the use of mesophilic polymerases in the amplification process, thereby increasing the speed and fidelity of the amplification process.
Patent AU-7299300-A (AU)
Title: Novel hydrocarbon base oil for lubricants with very high viscosity index
Inventor: BERTOMEU OLIVIER
IPC: C10G45/52
Filed: 2000-09-07
Abstract: The invention concerns a novel hydrocarbon base oil for lubricants, having a viscosity index not less than 130, comprising mainly long isoparaffinic hydrocarbon chains, branched over several carbon atoms. The invention is characterized in that said chains comprise a number of carbon atoms greater than 25 and have a ratio of the number of substituents consisting of at least two carbon atoms over the number of methyl-type substituents, not less than 0.9.
Patent AU-7502594-A (AU)
Title: Photosensitizers
Inventor: COOK MICHAEL JOHN
IPC: A61K31/409
Filed: 1994-08-24
Abstract: Susceptible tumors are treated by first sensitizing them to incident electromagnetic radiation by of a compound of the formula: where M is a diamagnetic metal ion or a diamagnetic metal compound or silicon or a compound of silicon or is 2H; one H being bonded to each of the two nitrogen atoms depicted as being bonded to M at positions 29 and 31; R1 to R25 are the same or different and are independently selected from C1-C20, alkyl, C2-C20 alkenyl, X-O-Y, X2COOX1, x2COONR1R11 and H; wherein X and X2 are independently selected from a chemical bond, -(CH2)n- where n is an integer from 1 to 20 and -(CH2)aCH=CH(CH2)b where a and b are independently selected from integers 0-20 and a+b totals from 0 to 20; X1 is independently selected from C1-20 alkyl, C2-20 alkenyl and H; R1 and R11 are independently selected from H, C1-20 alkyl, C2-20 alkenyl; and Y is independently selected from C1-20 alkyl, C2-20 alkenyl and H; provided that not all R1-R25 are simultaneously H; and provided that not all R1-R25 are simultaneously n-alkoxy Thereafter tumors so treated are exposed to incident electromagnetic radiation which is absorbed by the compound (I).
Patent AU-7608191-A (AU)
Title: Process for the preparation of diorganopolysiloxanes having alkoxy end groups
Inventor: COCCO ROGER
IPC: C08G77/18
Filed: 1991-04-26
Abstract: Process for the preparation of diorganopolysiloxanes with alkoxy end groups in the presence of a catalyst chosen from sodium hydroxide and potassium hydroxide. Use of these diorganopolysiloxanes for the preparation of single-component polysiloxane compositions which are stable in storage in the absence of moisture and which crosslink to elastomer in the presence of moisture.
Patent AU-7696396-A (AU)
Title: Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
Inventor: MASCIADRI RAFFAELLO
IPC: C07D239/49
Filed: 1996-11-22
Abstract: Diaminopyrimidines of general formula I <CHEM>  wherein   R<1>   signifies hydrogen, R<2>   signifies C3-5- omega -carboxyalkyl; R<3>   signifies C1-5-alkyl; and their pharmaceutically acceptable acid addition salts have antibiotic properties and can be used in the control or prevention of infectious diseases.
Patent AU-8162698-A (AU)
Title: Nucleic acid encoding a lectin-derived progenitor cell preservation factor
Inventor: COLUCCI M GABRIELLA
IPC: A61K35/12
Filed: 1998-06-23
Abstract: The invention relates to an isolated nucleic acid molecule that encodes a protein that is effective to preserve progenitor cells, such as hematopoietic progenitor cells. The nucleic acid comprises a sequence defined by SEQ ID NO:1, a homolog thereof, or a fragment thereof. The encoded protein has an amino acid sequence that comprises a sequence defined by SEQ ID NO:2, a homolog thereof, or a fragment thereof that contains an amino acid sequence TNNVLQVT. Methods of using the encoded protein for preserving progenitor cells in vitro, ex vivo, and in vivo are also described. The invention, therefore, include methods such as myeloablation therapies for cancer treatment wherein myeloid reconstitution is facilitated by means of the specified protein. Other therapeutic utilities are also enabled through the invention, for example, expanding progenitor cell populations ex vivo to increase chances of engraftation, improving conditions for transporting and storing progenitor cells, and facilitating gene therapy to treat and cure a broad range of life-threatening hematologic diseases.
Patent AU-8362601-A (AU)
Title: Quick-locking device for effecting hygienic transfer of flowable material from a container by piercing
Inventor: REDDY BALAKRISHNA
IPC: B31B19/90
Filed: 2001-10-25
Abstract: The invention relates to a device for effecting transfer of material from a container by piercing the container. The device includes a fitment member (30) comprising a portion having a bore and a base end capable of being attached to a container and a spout member (20) comprising a piercing end (21) and a portion of tube having an outer surface capable of mating in axial relationship with the portion of bore of the fitment member (30) so as to form mating surfaces. The device preferably has a locking assembly adapted to lock the fitment and spout members together in a position whereby the piercing end is in piercing engagement with the container. The device also includes at least one sealing member is arranged to seal the portion of tube and the portion of bore in a position between the locking assembly and the piercing end (21) so as to leave the mating surfaces downstream including the locking assembly substantially cleansed of the flowable material. <IMAGE>
Patent AU-8838698-A (AU)
Title: Process for the hydroisomerization of long-chain N-paraffins and catalyst suitable for the purpose
Inventor: FLEGO CRISTINA
IPC: B01J21/12
Filed: 1998-10-08
Abstract: Process for the hydroisomerization of long-chain n-paraffins which comprises isomerizing n-paraffins having a number of carbon atoms higher than 15 in the presence of hydrogen and a hydroisomerization catalyst which comprises:   a) a carrier of acid nature consisting of a silica and alumina gel amorphous to X-rays, with a molar ratio SiO2/Al2O3 ranging from 30/1 to 500/1, and having a surface area ranging from 500 to 1,000 m<2>/g, a porosity ranging from 0.3 to 0.6 ml/g and a pore diameter within the range of 10-40 Angstrom; b) a mixture of metals belonging to groups VIB and VIII deposited on the carrier in an overall quantity ranging from 2 to 50% by weight of the total (a) + (b).
Patent AU-8996282-A (AU)
Title: Spring element
Inventor: KEOWN JACK B
IPC: C04B28/26
Filed: 1982-10-15
Abstract: PCT No. PCT/CH82/00112 Sec. 371 Date Jun. 17, 1983 Sec. 102(e) Date Jun. 17, 1983 PCT Filed Oct. 15, 1982 PCT Pub. No. WO83/01495 PCT Pub. Date Apr. 28, 1983.A resilient support for receiving a force acting thereon along a certain direction, and wherein the force is opposed by a bearing counterforce acting at least partly along a direction opposite to said certain direction, and which includes a plurality of bar elements, at least two bar elements confronting one another, each of the two confronting bar elements having end regions, and forming a rod pair, a linking bar joining the confronting bar elements at a first set of connecting locations spaced at a distance from any end region of any of the confronting bar elements, two other bar elements, each connecting the end regions off the two confronting bar elements at a second set of connecting locations so as to form a closed structure therewith, the other bar elements forming a bar pair, at least two of the means being resilient in at least one of flexion and torsion, one force acting on a location of at least one of the other bar elements, the other force acting on the linking bar, at least one of the forces acting on a location of one of the bar means which is remote from the connecting location of the one of the linking bar or bar pair with the rod pair.
Patent AU-9090801-A (AU)
Title: Flexible heart valve having moveable commissures
Inventor: CAO DONGBU
IPC: A61F2/24
Filed: 2001-09-14
Abstract: A flexible prosthetic tissue-type heart valve having commissures that are substantially decoupled from a cusp support structure. The valve includes three leaflets having arcuate cusp edges and opposed concave shaped free edges, with outwardly-directed attachment tabs therebetween. A cusp support structure in either one or more pieces attaches to the leaflet cusp edges. Three commissures are each formed partly with an axially-extending insert member to which two adjacent leaflet tabs attach. An inverted V-shaped clip maintains close contact between the adjacent leaflet tabs and provides a stress-relieving clamping action in conjunction with the insert member. The insert member attaches about its lower end to base sections of the cusp support structure, or to an intermediate sewing ring, so that the commissures may pivot about the cusp support structure.
Patent BE-903078-A (BE)
Title: Antidazzle screen for night driving - comprises spectacles with areas of lenses blanked off to reduce light input
IPC: G02C7/10
Filed: 1985-08-14
Abstract: The anti-dazzle screen for night driving has filter panels placed vertically. These filter a part of the vision of each eye of the side of the road opposite that on which the vehicle is travelling. - The panels can be formed as tinted or smoked areas of a pair of spectacle lenses (12,13). The other parts of the lenses are clear (12,13). The filter area adjacent to the opposite side of the road can be slightly wider than the other.(3/3)
Patent BE-738276-A (BE)
Title: Prepn of 3-acyl-1,2,4-oxadiazoles useful in syn - of medicaments, in plant protection and as inter
Filed: 1969-09-01
Abstract: Prepn of 3-acyl 1,2,4-oxadiazoles useful in synthesis of medicaments in plant protection and raw materials for the prepn of other organic cpds M5-. Have the formula (I): (wherein R' is alkyl, cycloalkyl, aralkyl, aryl or heterocyclic gp. opt. substd. R2 is H, OH, alkyl, cycloalkyl, aralkyl, aryl or heterocyclic gp. opt. substd.) They are obtained, without using aminoglyoximes nitroso-imidazoles or imido-esters as starting materials, by nitrosation of N-substd. alpha aminoketones of formula (II) R'-CO-CH2-NH-CO-R2 (II) (wherein R' is as defined; R2 is alkyl, cycloalkyl, aralkyl, aryl or heterocyclic gp. opt. substd. or alkoxy), cyclising the O-substd. amido oximes obtained with dissociation of water when R' and R2 are as defined or with dissociation of alcohol when R2 is alkoxy, and reacting the resulting amido-oximes with carboxylic acid chlorides or anhydrides. Thus, 5-phenyl-3-benzoyl-1,2,4-oxadiazole is obtained (in 72% yield) from alpha-benzoylaminoacetophenone.
Patent BG-99340-A (BG)
Title: Closed mechanism for submachine gun
Inventor: MARINOV JANKO M
IPC: F41A3/00
Filed: 1995-01-10
Abstract: The mechanism operates on the principle of barrel recoil having a shot travel backwards. It contains a closed box (1) to the front end of which a guiding sleeve (2) is welded in which the barrel (3) is moving. In the rear part of the guiding sleeve (2) two symmetrical projections are formed having parallel walls and chamferings, and the barrel casing (3) being fitted to its fore end by means of threading. A spring (5) is inserted on the barrel (3). Two symmetrical projections with holes are formed at the rear end of barrel (3) in which two hollow locking rollers (7) are fitted by fixing pins which can be shifted both inwards and outwards. In the middle part of the closed box (1) guiding ribs are machined and a breech (8) moving along them which is narrower at its front part having two symmetrical arc-like cut-outs which are used for locking it to the barrel (3) by the locking rollers (7). A retracting spring (9) is fitted in a hole in the rear end of the breech (8) which by its rear end rests on the stem of the other retracting spring (10), its stem being fixed in a hole of the closed box (1) covered by a lid (11). The lid (11) is suspended on an axle (13) in its front part by a lug (12) to the cantelever of the closed box (14), and in its rear part it is held by the stem (10) of the retracting spring.
Patent BG-99435-A (BG)
Title: Method for the determination of the ovulation cycle
Inventor: CATT MICHAEL
IPC: G01N33/68
Filed: 1995-02-16
Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving repeated testing of the body fluid concentration of at least one analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least the pre-ovulation phase of the current ovulation cycle of the individual subject, wherein testing for said analyte concentration during the current ovulation cycle is commenced a plurality of days (preferably at least 5) following the onset of menses but at least 2 numerical days in advance of the earliest numerical day on which actual ovulation has occurred in one or more previous ovulation cycles in the same individual subject.